Refractive Surgery News

Bausch + Lomb announced it received FDA 510(k) clearance for its Crystalsert 2.6 injector.

LASIK retreatment based on manifest refraction in hyperopic eyes with a difference of no more than 1.00 D between cycloplegic and manifest refraction was safe, effective and predictable, according to a study.

LASEK with mitomycin C is safe to perform in eyes with myopia and thin corneas when preoperative corneal topography indicates no abnormalities, according to a retrospective study.

The refractive surgery articles that dominated news feeds in 2017 included study results comparing different types of surgery and insight into pain for patients.

Presentations at the annual American Academy of Ophthalmology meeting in November provided insight into recent refractive surgery developments.

With modern cataract surgery allowing for the correction of refractive error, including astigmatism and presbyopia, the refractive demands placed on this procedure are higher than ever.

Myopic or hyperopic eyes implanted with a presbyopia-correcting inlay at the time of LASIK correction have a similar epithelial remodeling response as emmetropic eyes implanted with the same inlay, independent of the type of refractive error, according to a study.

Implantation of a multifocal IOL in myopic eyes that had previously undergone laser refractive surgery resulted in good visual acuity and refractive results in a study.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Priya Narang, MS, discusses how the single-pass four-throw pupilloplasty technique can be effective in cases of Urrets-Zavalia syndrome.

The FDA has approved the Light Adjustable Lens and Light Delivery Device from RxSight, according to an FDA press release.